Reply: U-BIOPRED/BIOAIR proteins: inflammation or infection?
- PMID: 36202410
- PMCID: PMC9712852
- DOI: 10.1183/13993003.01795-2022
Reply: U-BIOPRED/BIOAIR proteins: inflammation or infection?
Abstract
Protein profiles in plasma remained associated with asthma severity in the European asthma cohort U-BIOPRED when controlling for previous history of respiratory infections
Conflict of interest statement
Conflict of interest: S-E. Dahlén reports personal fees for consultancy from AZ, Cayman Chemical, GSK, Novartis, Regeneron, Sanofi and Teva, outside the submitted work. The remaining authors disclose no potential conflicts of interest.
Figures
Comment on
-
Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation.Eur Respir J. 2022 Feb 17;59(2):2100142. doi: 10.1183/13993003.00142-2021. Print 2022 Feb. Eur Respir J. 2022. PMID: 34737220 Free PMC article. Clinical Trial.
-
U-BIOPRED/BIOAIR proteins: inflammation or infection?Eur Respir J. 2022 Dec 1;60(6):2200571. doi: 10.1183/13993003.00571-2022. Print 2022 Dec. Eur Respir J. 2022. PMID: 36202417 No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical